Significant Ownership of Steven Michael Oliveira
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Steven Michael Oliveira focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Oliveira Steven Michael - Individual
- Manager location
- New City, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Steven Michael Oliveira and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Steven Michael Oliveira
Significant Ownership of Steven Michael Oliveira
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Common Stock | 4.1% | $69,324 | -$788,375 | 161,218 | -92% | Oliveira Steven Michael | 01 Oct 2025 |
| FBRX | Forte Biosciences, Inc. | Common Stock, $0.001 par value | 2.4% | $6,797,265 | -$2,993,786 | 300,100 | -31% | Oliveira Steven Michael | 08 Jan 2026 |
Schedules 13D/G Reported by Steven Michael Oliveira:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.